N6-methyladenosine methyltransferases: functions, regulation, and clinical potential
N6-methyladenosine (m6A) has emerged as an abundant modification throughout the transcriptome with widespread functions in protein-coding and noncoding RNAs. It affects the fates of modified RNAs, including their stability, splicing, and/or translation, and thus plays important roles in posttranscri...
Uloženo v:
| Vydáno v: | Journal of hematology and oncology Ročník 14; číslo 1; s. 1 - 19 |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
BioMed Central
27.07.2021
BioMed Central Ltd Springer Nature B.V BMC |
| Témata: | |
| ISSN: | 1756-8722, 1756-8722 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | N6-methyladenosine (m6A) has emerged as an abundant modification throughout the transcriptome with widespread functions in protein-coding and noncoding RNAs. It affects the fates of modified RNAs, including their stability, splicing, and/or translation, and thus plays important roles in posttranscriptional regulation. To date, m6A methyltransferases have been reported to execute m6A deposition on distinct RNAs by their own or forming different complexes with additional partner proteins. In this review, we summarize the function of these m6A methyltransferases or complexes in regulating the key genes and pathways of cancer biology. We also highlight the progress in the use of m6A methyltransferases in mediating therapy resistance, including chemotherapy, targeted therapy, immunotherapy and radiotherapy. Finally, we discuss the current approaches and clinical potential of m6A methyltransferase-targeting strategies. |
|---|---|
| AbstractList | Abstract N6-methyladenosine (m6A) has emerged as an abundant modification throughout the transcriptome with widespread functions in protein-coding and noncoding RNAs. It affects the fates of modified RNAs, including their stability, splicing, and/or translation, and thus plays important roles in posttranscriptional regulation. To date, m6A methyltransferases have been reported to execute m6A deposition on distinct RNAs by their own or forming different complexes with additional partner proteins. In this review, we summarize the function of these m6A methyltransferases or complexes in regulating the key genes and pathways of cancer biology. We also highlight the progress in the use of m6A methyltransferases in mediating therapy resistance, including chemotherapy, targeted therapy, immunotherapy and radiotherapy. Finally, we discuss the current approaches and clinical potential of m6A methyltransferase-targeting strategies. N6-methyladenosine (m6A) has emerged as an abundant modification throughout the transcriptome with widespread functions in protein-coding and noncoding RNAs. It affects the fates of modified RNAs, including their stability, splicing, and/or translation, and thus plays important roles in posttranscriptional regulation. To date, m6A methyltransferases have been reported to execute m6A deposition on distinct RNAs by their own or forming different complexes with additional partner proteins. In this review, we summarize the function of these m6A methyltransferases or complexes in regulating the key genes and pathways of cancer biology. We also highlight the progress in the use of m6A methyltransferases in mediating therapy resistance, including chemotherapy, targeted therapy, immunotherapy and radiotherapy. Finally, we discuss the current approaches and clinical potential of m6A methyltransferase-targeting strategies. N6-methyladenosine (m6A) has emerged as an abundant modification throughout the transcriptome with widespread functions in protein-coding and noncoding RNAs. It affects the fates of modified RNAs, including their stability, splicing, and/or translation, and thus plays important roles in posttranscriptional regulation. To date, m6A methyltransferases have been reported to execute m6A deposition on distinct RNAs by their own or forming different complexes with additional partner proteins. In this review, we summarize the function of these m6A methyltransferases or complexes in regulating the key genes and pathways of cancer biology. We also highlight the progress in the use of m6A methyltransferases in mediating therapy resistance, including chemotherapy, targeted therapy, immunotherapy and radiotherapy. Finally, we discuss the current approaches and clinical potential of m6A methyltransferase-targeting strategies. Keywords: m6A, m6A methyltransferase, Cancer, Therapy resistance, Drug discovery N6-methyladenosine (m6A) has emerged as an abundant modification throughout the transcriptome with widespread functions in protein-coding and noncoding RNAs. It affects the fates of modified RNAs, including their stability, splicing, and/or translation, and thus plays important roles in posttranscriptional regulation. To date, m6A methyltransferases have been reported to execute m6A deposition on distinct RNAs by their own or forming different complexes with additional partner proteins. In this review, we summarize the function of these m6A methyltransferases or complexes in regulating the key genes and pathways of cancer biology. We also highlight the progress in the use of m6A methyltransferases in mediating therapy resistance, including chemotherapy, targeted therapy, immunotherapy and radiotherapy. Finally, we discuss the current approaches and clinical potential of m6A methyltransferase-targeting strategies.N6-methyladenosine (m6A) has emerged as an abundant modification throughout the transcriptome with widespread functions in protein-coding and noncoding RNAs. It affects the fates of modified RNAs, including their stability, splicing, and/or translation, and thus plays important roles in posttranscriptional regulation. To date, m6A methyltransferases have been reported to execute m6A deposition on distinct RNAs by their own or forming different complexes with additional partner proteins. In this review, we summarize the function of these m6A methyltransferases or complexes in regulating the key genes and pathways of cancer biology. We also highlight the progress in the use of m6A methyltransferases in mediating therapy resistance, including chemotherapy, targeted therapy, immunotherapy and radiotherapy. Finally, we discuss the current approaches and clinical potential of m6A methyltransferase-targeting strategies. |
| ArticleNumber | 117 |
| Audience | Academic |
| Author | Chen, Tian-Qi Fang, Ke Zeng, Zhan-Cheng Ye, Hua Chen, Yue-Qin Huang, Wei |
| Author_xml | – sequence: 1 givenname: Wei surname: Huang fullname: Huang, Wei organization: MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, School of Life Sciences, Sun Yat-Sen University – sequence: 2 givenname: Tian-Qi surname: Chen fullname: Chen, Tian-Qi organization: MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, School of Life Sciences, Sun Yat-Sen University – sequence: 3 givenname: Ke surname: Fang fullname: Fang, Ke organization: MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, School of Life Sciences, Sun Yat-Sen University – sequence: 4 givenname: Zhan-Cheng surname: Zeng fullname: Zeng, Zhan-Cheng organization: MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, School of Life Sciences, Sun Yat-Sen University – sequence: 5 givenname: Hua surname: Ye fullname: Ye, Hua organization: Department of Hepatobiliary, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University – sequence: 6 givenname: Yue-Qin orcidid: 0000-0002-5140-1993 surname: Chen fullname: Chen, Yue-Qin email: lsscyq@mail.sysu.edu.cn organization: MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory for Biocontrol, School of Life Sciences, Sun Yat-Sen University |
| BookMark | eNp9kstq3DAUhk1JaS7tC3RlKJQu4lQXS5a7KITQSyC0m3QtzkjHMxo00lSyC3n7asYpyYQSvJAlff-vczutjkIMWFVvKbmgVMmPmXLSioYw2hBKWd-oF9UJ7YRsVMfY0aP_4-o05zUhkvaMvKqOecupEJSdVLc_ZLPBcXXnwWKI2QWs5_2YIOQBE2TMn-phCmZ0MeTzOuFy8rDbnNcQbG28C86Ar7dxxDA68K-rlwP4jG_u17Pq19cvt1ffm5uf366vLm8aI6kYGwEcqSmx9NYibQfOFANpLMBgWS86MgwLpNKoRUmxY4jMQG8J62S5oIuen1XXs6-NsNbb5DaQ7nQEp_cHMS01pNEZj7plIAyznBhgLTNFLURXAlAI1rRy5_V59tpOiw1aUzJJ4A9MD2-CW-ll_KMVp1wpWQw-3Buk-HvCPOqNywa9h4BxypoJIXopJFEFffcEXccphVKqQknWKso4f6CWUBJwYYjlXbMz1ZdS9qrE35FCXfyHKp_FjTNlYAZXzg8E7x8JVgh-XOXop313D0E1gybFnBMO2rhx3_fygvOaEr0bQz2PoS490vsx1LsE2RPpvzo-K-KzKBc4LDE9VOUZ1V8m8O9x |
| CitedBy_id | crossref_primary_10_1002_art_42676 crossref_primary_10_2217_epi_2021_0334 crossref_primary_10_1016_j_heliyon_2023_e23668 crossref_primary_10_1002_jcp_31473 crossref_primary_10_1186_s12887_025_05783_6 crossref_primary_10_1007_s00018_025_05596_x crossref_primary_10_1002_jcp_30828 crossref_primary_10_3389_fcvm_2025_1559064 crossref_primary_10_1186_s12920_024_01916_5 crossref_primary_10_3389_fgene_2021_825109 crossref_primary_10_1016_j_ijbiomac_2025_147739 crossref_primary_10_1038_s41420_023_01645_1 crossref_primary_10_1186_s12943_023_01746_6 crossref_primary_10_1016_j_ncrna_2024_11_007 crossref_primary_10_1016_j_envint_2023_108386 crossref_primary_10_1016_j_biopha_2024_117421 crossref_primary_10_1038_s41598_022_20873_6 crossref_primary_10_3390_cancers15225478 crossref_primary_10_7554_eLife_69906 crossref_primary_10_7717_peerj_19940 crossref_primary_10_1186_s11658_023_00514_0 crossref_primary_10_1016_j_phymed_2024_156183 crossref_primary_10_1016_j_bcp_2023_115460 crossref_primary_10_1038_s12276_022_00735_x crossref_primary_10_3389_fgene_2022_935601 crossref_primary_10_1007_s12035_023_03735_8 crossref_primary_10_1002_kjm2_70010 crossref_primary_10_3389_fimmu_2025_1583039 crossref_primary_10_1016_j_yexcr_2024_114291 crossref_primary_10_1002_ijch_202300181 crossref_primary_10_1016_j_scitotenv_2024_172938 crossref_primary_10_1016_j_expneurol_2024_114948 crossref_primary_10_1111_cpr_70032 crossref_primary_10_1016_j_cellsig_2025_112145 crossref_primary_10_1016_j_etap_2023_104154 crossref_primary_10_1186_s12943_022_01620_x crossref_primary_10_1186_s41065_025_00393_9 crossref_primary_10_1186_s12935_021_02371_3 crossref_primary_10_3389_fimmu_2022_798583 crossref_primary_10_3390_biom14080952 crossref_primary_10_1002_ctm2_1318 crossref_primary_10_1016_j_biopha_2023_115171 crossref_primary_10_3390_biom13030561 crossref_primary_10_3390_biom12091224 crossref_primary_10_1007_s10142_023_01083_3 crossref_primary_10_1007_s10495_023_01885_7 crossref_primary_10_1007_s10565_024_09846_9 crossref_primary_10_1089_aid_2024_0003 crossref_primary_10_1186_s40164_022_00256_3 crossref_primary_10_3390_cells14181437 crossref_primary_10_1186_s12967_024_05668_9 crossref_primary_10_1016_j_jhazmat_2025_137432 crossref_primary_10_1038_s41598_024_60975_x crossref_primary_10_1186_s12943_022_01558_0 crossref_primary_10_3389_fonc_2024_1375942 crossref_primary_10_1016_j_bbagrm_2023_194927 crossref_primary_10_1172_JCI175703 crossref_primary_10_1016_j_phrs_2025_107825 crossref_primary_10_1038_s41440_024_01607_9 crossref_primary_10_1016_j_jdiacomp_2024_108801 crossref_primary_10_1038_s41421_022_00460_9 crossref_primary_10_1186_s10020_024_00782_2 crossref_primary_10_1016_j_heliyon_2024_e34031 crossref_primary_10_1016_j_heliyon_2024_e29817 crossref_primary_10_3389_fimmu_2021_765723 crossref_primary_10_1186_s13018_023_04254_x crossref_primary_10_1016_j_tranon_2021_101308 crossref_primary_10_1002_jcp_31448 crossref_primary_10_3389_fendo_2023_1132621 crossref_primary_10_1038_s41392_022_01175_9 crossref_primary_10_1007_s11427_024_2648_0 crossref_primary_10_1016_j_freeradbiomed_2025_07_033 crossref_primary_10_1002_prca_202200108 crossref_primary_10_1016_j_vetmic_2023_109887 crossref_primary_10_1016_j_ymeth_2022_03_008 crossref_primary_10_1016_j_hal_2025_102928 crossref_primary_10_1080_14737159_2022_2159381 crossref_primary_10_1016_j_yexcr_2024_114192 crossref_primary_10_3233_THC_230429 crossref_primary_10_4049_jimmunol_2300761 crossref_primary_10_1186_s10020_025_01130_8 crossref_primary_10_33549_physiolres_935289 crossref_primary_10_3389_fmicb_2024_1401997 crossref_primary_10_1016_j_ejmech_2024_116526 crossref_primary_10_3389_fimmu_2022_869759 crossref_primary_10_1016_j_tips_2023_09_013 crossref_primary_10_1111_jcmm_70291 crossref_primary_10_1186_s12935_024_03570_4 crossref_primary_10_1016_j_csbj_2022_09_017 crossref_primary_10_1016_j_bcp_2025_117033 crossref_primary_10_3389_fimmu_2025_1523503 crossref_primary_10_1007_s10142_025_01658_2 crossref_primary_10_1016_j_yjmcc_2024_05_013 crossref_primary_10_1016_j_tig_2025_05_001 crossref_primary_10_1016_j_drup_2023_101003 crossref_primary_10_1111_jgh_15999 crossref_primary_10_1128_MCB_00163_21 crossref_primary_10_3390_ijms23169272 crossref_primary_10_1002_1878_0261_13323 crossref_primary_10_1186_s12967_023_04651_0 crossref_primary_10_7717_peerj_12719 crossref_primary_10_1155_2022_3258400 crossref_primary_10_1016_j_ijbiomac_2025_143299 crossref_primary_10_1152_ajpcell_00881_2024 crossref_primary_10_1016_j_rbmo_2022_10_010 crossref_primary_10_1186_s40164_023_00451_w crossref_primary_10_2478_jtim_2023_0103 crossref_primary_10_1016_j_heliyon_2023_e14001 crossref_primary_10_1681_ASN_0000000000000428 crossref_primary_10_1016_j_tranon_2023_101764 crossref_primary_10_3390_ijms26072833 crossref_primary_10_3390_biomedicines12102211 crossref_primary_10_1007_s12011_022_03345_w crossref_primary_10_1016_j_ymthe_2025_08_042 crossref_primary_10_1002_tox_23530 crossref_primary_10_1002_bmb_21854 crossref_primary_10_1093_bib_bbaf361 crossref_primary_10_1007_s10266_025_01097_2 crossref_primary_10_1007_s12016_025_09041_6 crossref_primary_10_3389_fgene_2022_925652 crossref_primary_10_1038_s41598_022_27316_2 crossref_primary_10_3390_ijms26115233 crossref_primary_10_1186_s13046_023_02732_y crossref_primary_10_1016_j_heliyon_2023_e19816 crossref_primary_10_15252_embr_202255762 crossref_primary_10_1016_j_bbcan_2025_189299 crossref_primary_10_1186_s13287_024_03846_6 crossref_primary_10_1016_j_biopha_2024_116185 crossref_primary_10_1016_j_intimp_2024_113759 crossref_primary_10_3389_fimmu_2024_1464042 crossref_primary_10_1038_s42003_025_07972_6 crossref_primary_10_62347_XYKG2252 crossref_primary_10_1016_j_biopha_2023_116066 crossref_primary_10_4239_wjd_v16_i3_102126 crossref_primary_10_1007_s13577_023_00933_3 crossref_primary_10_3389_fimmu_2025_1516473 crossref_primary_10_2174_0115748936332078240826105023 crossref_primary_10_1002_jmv_70332 crossref_primary_10_3390_cancers14184502 crossref_primary_10_1136_jitc_2023_007415 crossref_primary_10_1016_j_tube_2023_102337 crossref_primary_10_3389_fimmu_2024_1456891 crossref_primary_10_1016_j_bbagrm_2023_194967 crossref_primary_10_1016_j_jare_2024_04_016 crossref_primary_10_1016_j_toxlet_2024_12_007 crossref_primary_10_1038_s41419_023_06121_3 crossref_primary_10_1016_j_drudis_2023_103875 crossref_primary_10_2147_IJGM_S519741 crossref_primary_10_1016_j_medj_2023_09_001 crossref_primary_10_1186_s13148_023_01586_7 crossref_primary_10_1016_j_bcp_2023_115750 crossref_primary_10_1038_s41392_025_02266_z crossref_primary_10_3389_fimmu_2024_1374390 crossref_primary_10_26508_lsa_202302240 crossref_primary_10_1007_s10495_022_01784_3 crossref_primary_10_1016_j_bbcan_2023_188873 crossref_primary_10_1186_s40164_022_00357_z crossref_primary_10_1002_mc_23830 crossref_primary_10_1261_rna_080259_124 crossref_primary_10_3390_ijms24097873 crossref_primary_10_1038_s41419_024_06727_1 crossref_primary_10_3389_fphar_2022_873030 crossref_primary_10_3389_fimmu_2024_1344995 crossref_primary_10_1111_nph_20008 crossref_primary_10_1016_j_biopha_2023_114669 crossref_primary_10_1186_s10020_025_01295_2 crossref_primary_10_1186_s12964_024_01854_w crossref_primary_10_3389_fonc_2023_1229168 crossref_primary_10_1002_cbin_70015 crossref_primary_10_1093_jleuko_qiae021 crossref_primary_10_1016_j_cellsig_2025_111873 |
| Cites_doi | 10.1038/s41389-020-0229-9 10.1038/s41388-019-0683-z 10.1093/nar/gkz619 10.1016/j.stem.2017.11.016 10.1016/j.ccell.2020.04.005 10.1111/jcmm.16114 10.1016/j.celrep.2020.108544 10.1038/ncb758 10.1186/s13045-019-0748-z 10.1016/j.cell.2014.05.010 10.15252/embr.201744940 10.1016/j.molcel.2016.05.041 10.1016/j.cell.2012.05.003 10.1186/s12943-020-01249-8 10.1126/sciadv.abd4742 10.1186/s12943-019-1119-7 10.1182/blood-2012-05-378943 10.1038/nrd4236 10.1038/s41467-021-21828-7 10.1186/s13045-020-00966-3 10.1038/nchembio.1432 10.1016/j.bbrc.2016.11.077 10.1016/j.cell.2017.04.005 10.1016/j.cell.2021.03.062 10.1038/nature21671 10.1186/s40364-020-00212-5 10.1186/s13045-020-00872-8 10.1096/fasebj.10.4.8647346 10.1038/s41419-020-03148-8 10.1038/nm.4416 10.1038/s41392-020-00299-0 10.1016/0955-2863(90)90070-2 10.1016/j.molcel.2020.06.017 10.1016/j.ccell.2020.04.017 10.1021/acschembio.5b00812 10.1038/s41587-020-0572-6 10.1158/2159-8290.CD-15-0011 10.1016/j.lfs.2021.119399 10.1053/j.gastro.2020.11.013 10.1038/s41389-020-00290-y 10.7150/thno.40144 10.1016/0006-2952(82)90171-X 10.1016/j.celrep.2014.05.048 10.1038/nature19342 10.1038/s41585-020-0298-8 10.1038/nrc723 10.1186/s40364-020-00203-6 10.1038/cr.2014.152 10.1186/s13045-020-00909-y 10.1186/s13046-020-01714-8 10.1007/s10557-016-6711-0 10.1074/jbc.M109.040113 10.1038/s41568-020-00308-y 10.1038/s41419-021-03558-2 10.1016/S0021-9258(17)32497-3 10.7150/ijbs.20052 10.1038/nature18298 10.1186/s40364-021-00285-w 10.1038/35042675 10.1038/s41556-018-0045-z 10.1016/j.stem.2007.02.001 10.1126/science.1164368 10.1002/cmdc.202000011 10.1038/nrc2657 10.1038/s41589-019-0327-1 10.1111/jcmm.15738 10.1186/s13045-020-00977-0 10.3389/fonc.2020.00003 10.1038/d41573-019-00179-5 10.1038/s41586-021-03536-w 10.1186/1756-8722-6-23 10.1038/s41421-018-0019-0 10.1002/hep.31313 10.1186/s13045-019-0805-7 10.1186/s40364-020-00196-2 10.2147/CMAR.S181058 10.1016/0022-2836(86)90498-5 10.1038/s41388-019-0861-z 10.1038/nrd.2018.169 10.1186/s40364-020-00244-x 10.1073/pnas.71.10.3971 10.1016/j.molcel.2012.10.015 10.1111/jcmm.16478 10.1155/2020/8849218 10.1016/j.canlet.2017.11.018 10.1002/cmdc.202100291 10.1016/j.molcel.2018.02.015 10.7150/ijbs.45886 10.1038/onc.2017.351 10.1016/j.cell.2011.02.013 10.1186/s13045-020-00990-3 10.3389/fonc.2021.624395 10.1016/j.molcel.2019.04.025 10.1038/s41586-018-0538-8 10.1016/j.cell.2017.05.016 10.1038/s12276-020-00510-w 10.1016/j.ccell.2019.03.006 10.1186/s13045-020-00951-w 10.1038/s41580-019-0168-5 10.1038/s41467-020-17495-9 10.1186/s40364-019-0178-7 10.1038/nm.4165 10.1016/j.bbrc.2020.01.042 10.1186/s13045-019-0760-3 10.1186/s13045-020-00927-w 10.1038/nrc883 10.15252/embj.2019103181 10.1016/j.bcp.2018.12.014 10.7150/jca.42338 10.1111/acel.13298 10.1038/s41419-020-02847-6 10.1111/cpr.12768 10.1186/s13045-020-01000-2 10.1126/science.1258096 10.7164/antibiotics.26.463 10.1038/nature14281 10.1016/j.bbrc.2019.07.058 10.1186/s13045-019-0818-2 10.1016/0022-2836(88)90139-8 10.1002/jcla.23655 10.1126/science.aao0409 10.1016/j.ccell.2020.02.004 10.1186/s13045-020-00924-z 10.1038/s41419-020-03049-w 10.1016/j.ymthe.2020.09.028 10.1016/j.gene.2019.144076 10.3389/fgene.2020.617174 10.1038/s41556-018-0174-4 10.1111/jcmm.15736 10.1158/0008-5472.CAN-18-2868 10.1261/rna.064063.117 10.3389/fonc.2020.00115 10.1186/s13045-017-0410-6 10.1002/iub.2410 10.1038/s41589-018-0184-3 10.1038/s41467-021-22424-5 10.1016/j.cell.2012.03.003 10.1016/j.celrep.2019.02.100 10.1186/s12943-020-01281-8 10.1186/s13045-017-0430-2 10.1186/s13045-020-00895-1 10.1016/j.envpol.2019.113908 10.1016/j.cmet.2021.03.024 10.1186/s13045-020-00945-8 10.1186/s40364-020-00225-0 10.1038/s41467-021-21514-8 10.1016/j.omtn.2020.01.033 10.1038/s41419-019-1585-2 10.1038/s41422-020-00397-2 10.1016/j.cell.2017.05.003 10.1038/nchembio.687 10.1038/s41419-020-02998-6 10.1016/j.molcel.2016.03.021 10.1002/jcp.29645 10.15252/embj.2020104514 10.1186/s13046-021-01934-6 10.1038/nature11112 10.1038/nmeth.3453 10.1016/j.stem.2012.12.007 10.1016/j.devcel.2021.01.015 10.1002/gcc.20604 10.1038/nrc3185 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021 COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021. The Author(s). |
| Copyright_xml | – notice: The Author(s) 2021 – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021. The Author(s). |
| DBID | C6C AAYXX CITATION 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU COVID DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s13045-021-01129-8 |
| DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Coronavirus Research Database ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Proquest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition Coronavirus Research Database ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database CrossRef MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1756-8722 |
| EndPage | 19 |
| ExternalDocumentID | oai_doaj_org_article_42a5c2d30ca242c1b95575a38eadc469 PMC8313886 A669857570 10_1186_s13045_021_01129_8 |
| GrantInformation_xml | – fundername: nsfc grantid: 82000170; 81772621 – fundername: ; grantid: 82000170; 81772621 |
| GroupedDBID | --- 0R~ 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IEA IHR IHW INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP ~8M AAYXX AFFHD CITATION ALIPV 3V. 7T5 7XB 8FK AZQEC COVID DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c615t-5a3e1c3439dde14f3282a6cdaafd29570ffbe16c8b02172ee2ca9d0276ffb1b93 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 194 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000678066100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1756-8722 |
| IngestDate | Fri Oct 03 12:41:03 EDT 2025 Tue Nov 04 01:45:42 EST 2025 Wed Oct 01 14:24:58 EDT 2025 Sat Oct 18 23:52:15 EDT 2025 Tue Nov 11 09:57:53 EST 2025 Tue Nov 04 17:57:17 EST 2025 Thu May 22 21:22:40 EDT 2025 Sat Nov 29 06:33:50 EST 2025 Tue Nov 18 21:40:39 EST 2025 Sat Sep 06 07:24:28 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | m6A Therapy resistance Drug discovery m6A methyltransferase Cancer |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c615t-5a3e1c3439dde14f3282a6cdaafd29570ffbe16c8b02172ee2ca9d0276ffb1b93 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-5140-1993 |
| OpenAccessLink | https://doaj.org/article/42a5c2d30ca242c1b95575a38eadc469 |
| PMID | 34315512 |
| PQID | 2562481233 |
| PQPubID | 54946 |
| PageCount | 19 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_42a5c2d30ca242c1b95575a38eadc469 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8313886 proquest_miscellaneous_2555965608 proquest_journals_2562481233 gale_infotracmisc_A669857570 gale_infotracacademiconefile_A669857570 gale_healthsolutions_A669857570 crossref_citationtrail_10_1186_s13045_021_01129_8 crossref_primary_10_1186_s13045_021_01129_8 springer_journals_10_1186_s13045_021_01129_8 |
| PublicationCentury | 2000 |
| PublicationDate | 2021-07-27 |
| PublicationDateYYYYMMDD | 2021-07-27 |
| PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-27 day: 27 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London |
| PublicationTitle | Journal of hematology and oncology |
| PublicationTitleAbbrev | J Hematol Oncol |
| PublicationYear | 2021 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | P Wang (1129_CR80) 2017; 358 J Zhang (1129_CR122) 2016; 11 BE Maden (1129_CR7) 1988; 201 S Jones (1129_CR79) 2008; 321 H Uranishi (1129_CR85) 2009; 284 X Wang (1129_CR145) 2021; 56 R Nusse (1129_CR39) 2017; 169 JV McGowan (1129_CR99) 2017; 31 M Cully (1129_CR120) 2019; 18 H Ma (1129_CR30) 2019; 15 P Krafcikova (1129_CR124) 2020; 11 F Gao (1129_CR111) 2021; 25 M Mendel (1129_CR154) 2021; 184 L Cassetta (1129_CR115) 2018; 17 T Zhu (1129_CR14) 2014; 24 ZF Lim (1129_CR88) 2019; 12 X Liu (1129_CR96) 2021; 40 A Visvanathan (1129_CR76) 2018; 37 L Yang (1129_CR116) 2017; 10 V Moroz-Omori Elena (1129_CR127) 2021 Q Gao (1129_CR77) 2020; 2020 Y Fujita (1129_CR84) 2002; 4 N van Tran (1129_CR29) 2019; 47 H Chen (1129_CR49) 2021; 160 H Ramalingam (1129_CR132) 2021; 33 X Lai (1129_CR52) 2021; 25 D Fu (1129_CR101) 2012; 12 AC Komor (1129_CR148) 2017; 169 J Wei (1129_CR92) 2020; 24 HG Williams-Ashman (1129_CR125) 1982; 31 DP Patil (1129_CR28) 2016; 537 H Shen (1129_CR16) 2020; 8 DAJ Lopez (1129_CR56) 2020; 13 K Miyamoto (1129_CR78) 2007; 1 F Zheng (1129_CR135) 2021; 9 PC Ma (1129_CR109) 2008; 47 H Weng (1129_CR34) 2018; 22 S Rottenberg (1129_CR91) 2021; 21 J Wen (1129_CR24) 2018; 69 W Zhao (1129_CR37) 2020; 20 C Wilson (1129_CR150) 2020; 38 R Su (1129_CR163) 2020; 38 B Vogelstein (1129_CR60) 2000; 408 AN Hata (1129_CR69) 2015; 5 X Wang (1129_CR22) 2016; 534 A Sarkar (1129_CR75) 2013; 12 R Miao (1129_CR87) 2020; 235 S Ma (1129_CR2) 2019; 12 D Hanahan (1129_CR17) 2011; 144 C Zeng (1129_CR19) 2020; 13 Y Yue (1129_CR26) 2018; 4 H Qin (1129_CR165) 2020; 13 T Zhao (1129_CR63) 2020; 259 F Peng (1129_CR44) 2021; 31 Y Xiang (1129_CR103) 2017; 543 SC Lee (1129_CR155) 2016; 22 RK Bedi (1129_CR126) 2020; 15 M Du (1129_CR142) 2017; 482 CH Pui (1129_CR134) 2012; 120 Y Sun (1129_CR53) 2020; 11 H Huang (1129_CR15) 2018; 20 M Cheng (1129_CR35) 2019; 38 Z Song (1129_CR94) 2021; 276 S Selberg (1129_CR121) 2019; 26 KE Pendleton (1129_CR4) 2017; 169 MB Uddin (1129_CR62) 2019; 160 E Scholler (1129_CR25) 2018; 24 S Zaccara (1129_CR1) 2019; 20 X Cui (1129_CR140) 2020; 53 H Zhang (1129_CR58) 2020; 24 L Huang (1129_CR105) 2020; 13 D Yi (1129_CR129) 2020; 43 Y Yuan (1129_CR36) 2020; 11 H Shi (1129_CR157) 2019; 74 Z Sun (1129_CR143) 2021; 20 JA Bokar (1129_CR20) 1997; 3 D Liu (1129_CR107) 2019; 7 LP Vu (1129_CR33) 2017; 23 DD Yang (1129_CR38) 2020; 10 J Xu (1129_CR42) 2020; 19 H Chang (1129_CR47) 2020; 13 Q Wang (1129_CR158) 2020; 13 J Wang (1129_CR40) 2020; 10 CR Alarcon (1129_CR3) 2015; 519 M Wang (1129_CR66) 2020; 19 L Zhu (1129_CR93) 2019; 10 H Ma (1129_CR95) 2021; 73 D Dominissini (1129_CR10) 2012; 485 MN Saha (1129_CR67) 2013; 6 G Jia (1129_CR12) 2011; 7 JY Qian (1129_CR86) 2019; 38 S Cory (1129_CR72) 2002; 2 J Liu (1129_CR54) 2018; 20 KH Khoo (1129_CR68) 2014; 13 JA Doudna (1129_CR147) 2014; 346 L Liu (1129_CR41) 2019; 18 JD Finkelstein (1129_CR131) 1990; 1 Y Zhang (1129_CR46) 2020; 13 YM Sun (1129_CR137) 2020; 13 J Mann (1129_CR97) 2002; 2 X Cai (1129_CR138) 2018; 415 G Sharma (1129_CR151) 2021; 29 CT Kwok (1129_CR61) 2017; 10 J Liu (1129_CR11) 2014; 10 K Taketo (1129_CR104) 2018; 52 E Yankova (1129_CR128) 2021; 593 X Yang (1129_CR156) 2020; 8 BE Maden (1129_CR6) 1986; 189 T Abbas (1129_CR64) 2009; 9 X Liu (1129_CR136) 2021; 11 C Zhang (1129_CR102) 2020; 79 B Linder (1129_CR5) 2015; 12 PK Chiang (1129_CR130) 1996; 10 N Ding (1129_CR108) 2020; 16 CV Dang (1129_CR32) 2012; 149 AS Warda (1129_CR31) 2017; 18 WT Wang (1129_CR81) 2020; 13 H Huang (1129_CR82) 2020; 37 WT Wang (1129_CR144) 2019; 12 W Wei (1129_CR141) 2019; 11 S Wanna-Udom (1129_CR159) 2020; 524 XM Liu (1129_CR149) 2019; 15 Y He (1129_CR161) 2020; 13 Y Wang (1129_CR27) 2021; 12 H Wang (1129_CR70) 2020; 722 P Wu (1129_CR119) 2021; 12 M Carceles-Cordon (1129_CR90) 2020; 17 C Xue (1129_CR166) 2020; 8 R Desrosiers (1129_CR8) 1974; 71 Z Yang (1129_CR45) 2020; 39 F Li (1129_CR71) 2019; 79 S Liu (1129_CR110) 2020; 11 Y Huang (1129_CR162) 2019; 35 H He (1129_CR139) 2019; 517 S Schwartz (1129_CR18) 2014; 8 R Liu (1129_CR59) 2020; 11 M Farhan (1129_CR73) 2017; 13 PD Hsu (1129_CR146) 2014; 157 X Liu (1129_CR48) 2021; 35 X Wang (1129_CR55) 2021; 12 Z Lin (1129_CR74) 2020; 39 M Tajan (1129_CR133) 2020; 37 JY Sun (1129_CR89) 2020; 8 S Chen (1129_CR50) 2020; 11 L Cheng (1129_CR65) 2021; 10 J Choe (1129_CR160) 2018; 561 S Lin (1129_CR83) 2016; 62 T Zhou (1129_CR112) 2020; 5 J Tong (1129_CR114) 2021; 7 G Delaney (1129_CR118) 2005; 104 S Sun (1129_CR153) 2020; 11 R Zhang (1129_CR43) 2020; 9 J Yu (1129_CR106) 2020; 8 Y Lin (1129_CR113) 2019; 12 Y Zhao (1129_CR164) 2020; 13 GW Kim (1129_CR51) 2021; 73 B Rong (1129_CR152) 2020; 33 P Wang (1129_CR23) 2016; 63 L Wang (1129_CR117) 2020; 39 RL Hamil (1129_CR123) 1973; 26 H Yin (1129_CR57) 2021; 12 Z Chen (1129_CR98) 2020; 10 X Pan (1129_CR100) 2021; 53 KD Meyer (1129_CR9) 2012; 149 G Zheng (1129_CR13) 2013; 49 JA Bokar (1129_CR21) 1994; 269 |
| References_xml | – volume: 9 start-page: 45 issue: 5 year: 2020 ident: 1129_CR43 publication-title: Oncogenesis doi: 10.1038/s41389-020-0229-9 – volume: 38 start-page: 3667 issue: 19 year: 2019 ident: 1129_CR35 publication-title: Oncogene doi: 10.1038/s41388-019-0683-z – volume: 47 start-page: 7719 issue: 15 year: 2019 ident: 1129_CR29 publication-title: Nucleic Acids Res doi: 10.1093/nar/gkz619 – volume: 22 start-page: 191 issue: 2 year: 2018 ident: 1129_CR34 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2017.11.016 – volume: 37 start-page: 767 issue: 6 year: 2020 ident: 1129_CR133 publication-title: Cancer Cell doi: 10.1016/j.ccell.2020.04.005 – volume: 25 start-page: 2418 issue: 5 year: 2021 ident: 1129_CR111 publication-title: J Cell Mol Med doi: 10.1111/jcmm.16114 – volume: 33 start-page: 108544 issue: 12 year: 2020 ident: 1129_CR152 publication-title: Cell Rep doi: 10.1016/j.celrep.2020.108544 – volume: 4 start-page: 222 issue: 3 year: 2002 ident: 1129_CR84 publication-title: Nat Cell Biol doi: 10.1038/ncb758 – volume: 12 start-page: 55 issue: 1 year: 2019 ident: 1129_CR144 publication-title: J Hematol Oncol doi: 10.1186/s13045-019-0748-z – volume: 157 start-page: 1262 issue: 6 year: 2014 ident: 1129_CR146 publication-title: Cell doi: 10.1016/j.cell.2014.05.010 – volume: 18 start-page: 2004 issue: 11 year: 2017 ident: 1129_CR31 publication-title: EMBO Rep doi: 10.15252/embr.201744940 – volume: 63 start-page: 306 issue: 2 year: 2016 ident: 1129_CR23 publication-title: Mol Cell doi: 10.1016/j.molcel.2016.05.041 – volume: 149 start-page: 1635 issue: 7 year: 2012 ident: 1129_CR9 publication-title: Cell doi: 10.1016/j.cell.2012.05.003 – volume: 19 start-page: 130 issue: 1 year: 2020 ident: 1129_CR66 publication-title: Mol Cancer doi: 10.1186/s12943-020-01249-8 – volume: 7 start-page: eabd4742 issue: 18 year: 2021 ident: 1129_CR114 publication-title: Sci Adv doi: 10.1126/sciadv.abd4742 – volume: 18 start-page: 188 issue: 1 year: 2019 ident: 1129_CR41 publication-title: Mol Cancer doi: 10.1186/s12943-019-1119-7 – volume: 120 start-page: 1165 issue: 6 year: 2012 ident: 1129_CR134 publication-title: Blood doi: 10.1182/blood-2012-05-378943 – volume: 13 start-page: 217 issue: 3 year: 2014 ident: 1129_CR68 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd4236 – volume: 12 start-page: 1518 issue: 1 year: 2021 ident: 1129_CR55 publication-title: Nat Commun doi: 10.1038/s41467-021-21828-7 – volume: 13 start-page: 136 issue: 1 year: 2020 ident: 1129_CR56 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00966-3 – volume: 10 start-page: 93 issue: 2 year: 2014 ident: 1129_CR11 publication-title: Nat Chem Biol doi: 10.1038/nchembio.1432 – volume: 482 start-page: 582 issue: 4 year: 2017 ident: 1129_CR142 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2016.11.077 – volume: 169 start-page: 559 issue: 3 year: 2017 ident: 1129_CR148 publication-title: Cell doi: 10.1016/j.cell.2017.04.005 – volume: 184 start-page: 3125 issue: 12 year: 2021 ident: 1129_CR154 publication-title: Cell doi: 10.1016/j.cell.2021.03.062 – volume: 543 start-page: 573 issue: 7646 year: 2017 ident: 1129_CR103 publication-title: Nature doi: 10.1038/nature21671 – volume: 8 start-page: 35 year: 2020 ident: 1129_CR89 publication-title: Biomark Res doi: 10.1186/s40364-020-00212-5 – volume: 13 start-page: 35 issue: 1 year: 2020 ident: 1129_CR164 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00872-8 – volume: 10 start-page: 471 issue: 4 year: 1996 ident: 1129_CR130 publication-title: FASEB J doi: 10.1096/fasebj.10.4.8647346 – volume: 11 start-page: 969 issue: 11 year: 2020 ident: 1129_CR110 publication-title: Cell Death Dis doi: 10.1038/s41419-020-03148-8 – volume: 23 start-page: 1369 issue: 11 year: 2017 ident: 1129_CR33 publication-title: Nat Med doi: 10.1038/nm.4416 – volume: 5 start-page: 296 issue: 1 year: 2020 ident: 1129_CR112 publication-title: Signal Transduct Target Ther doi: 10.1038/s41392-020-00299-0 – volume: 1 start-page: 228 issue: 5 year: 1990 ident: 1129_CR131 publication-title: J Nutr Biochem doi: 10.1016/0955-2863(90)90070-2 – volume: 79 start-page: 425 issue: 3 year: 2020 ident: 1129_CR102 publication-title: Mol Cell doi: 10.1016/j.molcel.2020.06.017 – volume: 38 start-page: 79 issue: 1 year: 2020 ident: 1129_CR163 publication-title: Cancer Cell doi: 10.1016/j.ccell.2020.04.017 – volume: 52 start-page: 621 issue: 2 year: 2018 ident: 1129_CR104 publication-title: Int J Oncol – volume: 11 start-page: 583 issue: 3 year: 2016 ident: 1129_CR122 publication-title: ACS Chem Biol doi: 10.1021/acschembio.5b00812 – volume: 38 start-page: 1431 issue: 12 year: 2020 ident: 1129_CR150 publication-title: Nat Biotechnol doi: 10.1038/s41587-020-0572-6 – volume: 5 start-page: 475 issue: 5 year: 2015 ident: 1129_CR69 publication-title: Cancer Discov doi: 10.1158/2159-8290.CD-15-0011 – volume: 276 start-page: 119399 year: 2021 ident: 1129_CR94 publication-title: Life Sci doi: 10.1016/j.lfs.2021.119399 – volume: 160 start-page: 1284 issue: 4 year: 2021 ident: 1129_CR49 publication-title: Gastroenterology doi: 10.1053/j.gastro.2020.11.013 – volume: 10 start-page: 7 issue: 1 year: 2021 ident: 1129_CR65 publication-title: Oncogenesis doi: 10.1038/s41389-020-00290-y – volume: 10 start-page: 3382 issue: 8 year: 2020 ident: 1129_CR98 publication-title: Theranostics doi: 10.7150/thno.40144 – volume: 104 start-page: 1129 issue: 6 year: 2005 ident: 1129_CR118 publication-title: Cancer-Am Cancer Soc – volume: 31 start-page: 277 issue: 3 year: 1982 ident: 1129_CR125 publication-title: Biochem Pharmacol doi: 10.1016/0006-2952(82)90171-X – volume: 8 start-page: 284 issue: 1 year: 2014 ident: 1129_CR18 publication-title: Cell Rep doi: 10.1016/j.celrep.2014.05.048 – volume: 537 start-page: 369 issue: 7620 year: 2016 ident: 1129_CR28 publication-title: Nature doi: 10.1038/nature19342 – volume: 17 start-page: 292 issue: 5 year: 2020 ident: 1129_CR90 publication-title: Nat Rev Urol doi: 10.1038/s41585-020-0298-8 – volume: 2 start-page: 143 issue: 2 year: 2002 ident: 1129_CR97 publication-title: Nat Rev Cancer doi: 10.1038/nrc723 – volume: 8 start-page: 24 year: 2020 ident: 1129_CR16 publication-title: Biomark Res doi: 10.1186/s40364-020-00203-6 – volume: 24 start-page: 1493 issue: 12 year: 2014 ident: 1129_CR14 publication-title: Cell Res doi: 10.1038/cr.2014.152 – volume: 13 start-page: 78 issue: 1 year: 2020 ident: 1129_CR81 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00909-y – volume: 39 start-page: 203 issue: 1 year: 2020 ident: 1129_CR45 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-020-01714-8 – volume: 31 start-page: 63 issue: 1 year: 2017 ident: 1129_CR99 publication-title: Cardiovasc Drugs Ther doi: 10.1007/s10557-016-6711-0 – volume: 284 start-page: 26106 issue: 38 year: 2009 ident: 1129_CR85 publication-title: J Biol Chem doi: 10.1074/jbc.M109.040113 – volume: 21 start-page: 37 issue: 1 year: 2021 ident: 1129_CR91 publication-title: Nat Rev Cancer doi: 10.1038/s41568-020-00308-y – volume: 12 start-page: 298 issue: 4 year: 2021 ident: 1129_CR119 publication-title: Cell Death Dis doi: 10.1038/s41419-021-03558-2 – volume: 43 start-page: 1375 issue: 5 year: 2020 ident: 1129_CR129 publication-title: Oncol Rep – volume: 269 start-page: 17697 issue: 26 year: 1994 ident: 1129_CR21 publication-title: J Biol Chem doi: 10.1016/S0021-9258(17)32497-3 – volume: 13 start-page: 815 issue: 7 year: 2017 ident: 1129_CR73 publication-title: Int J Biol Sci doi: 10.7150/ijbs.20052 – volume: 534 start-page: 575 issue: 7608 year: 2016 ident: 1129_CR22 publication-title: Nature doi: 10.1038/nature18298 – volume: 9 start-page: 28 issue: 1 year: 2021 ident: 1129_CR135 publication-title: Biomark Res doi: 10.1186/s40364-021-00285-w – volume: 408 start-page: 307 issue: 6810 year: 2000 ident: 1129_CR60 publication-title: Nature doi: 10.1038/35042675 – volume: 20 start-page: 285 issue: 3 year: 2018 ident: 1129_CR15 publication-title: Nat Cell Biol doi: 10.1038/s41556-018-0045-z – volume: 1 start-page: 101 issue: 1 year: 2007 ident: 1129_CR78 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2007.02.001 – volume: 321 start-page: 1801 issue: 5897 year: 2008 ident: 1129_CR79 publication-title: Science doi: 10.1126/science.1164368 – volume: 15 start-page: 744 issue: 9 year: 2020 ident: 1129_CR126 publication-title: ChemMedChem doi: 10.1002/cmdc.202000011 – volume: 9 start-page: 400 issue: 6 year: 2009 ident: 1129_CR64 publication-title: Nat Rev Cancer doi: 10.1038/nrc2657 – volume: 15 start-page: 865 issue: 9 year: 2019 ident: 1129_CR149 publication-title: Nat Chem Biol doi: 10.1038/s41589-019-0327-1 – volume: 24 start-page: 11366 issue: 19 year: 2020 ident: 1129_CR92 publication-title: J Cell Mol Med doi: 10.1111/jcmm.15738 – volume: 13 start-page: 143 issue: 1 year: 2020 ident: 1129_CR105 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00977-0 – volume: 10 start-page: 3 year: 2020 ident: 1129_CR40 publication-title: Front Oncol doi: 10.3389/fonc.2020.00003 – volume: 18 start-page: 892 issue: 12 year: 2019 ident: 1129_CR120 publication-title: Nat Rev Drug Discov doi: 10.1038/d41573-019-00179-5 – volume: 593 start-page: 597 issue: 7860 year: 2021 ident: 1129_CR128 publication-title: Nature doi: 10.1038/s41586-021-03536-w – volume: 6 start-page: 23 year: 2013 ident: 1129_CR67 publication-title: J Hematol Oncol doi: 10.1186/1756-8722-6-23 – volume: 4 start-page: 10 year: 2018 ident: 1129_CR26 publication-title: Cell Discov doi: 10.1038/s41421-018-0019-0 – volume: 73 start-page: 533 issue: 2 year: 2021 ident: 1129_CR51 publication-title: Hepatology doi: 10.1002/hep.31313 – volume: 12 start-page: 121 issue: 1 year: 2019 ident: 1129_CR2 publication-title: J Hematol Oncol doi: 10.1186/s13045-019-0805-7 – volume: 8 start-page: 17 year: 2020 ident: 1129_CR106 publication-title: Biomark Res doi: 10.1186/s40364-020-00196-2 – volume: 11 start-page: 1177 year: 2019 ident: 1129_CR141 publication-title: Cancer Manag Res doi: 10.2147/CMAR.S181058 – volume: 189 start-page: 681 issue: 4 year: 1986 ident: 1129_CR6 publication-title: J Mol Biol doi: 10.1016/0022-2836(86)90498-5 – volume: 38 start-page: 6123 issue: 33 year: 2019 ident: 1129_CR86 publication-title: Oncogene doi: 10.1038/s41388-019-0861-z – volume: 17 start-page: 887 issue: 12 year: 2018 ident: 1129_CR115 publication-title: Nat Rev Drug Discov doi: 10.1038/nrd.2018.169 – volume: 8 start-page: 61 issue: 1 year: 2020 ident: 1129_CR156 publication-title: Biomark Res doi: 10.1186/s40364-020-00244-x – volume: 71 start-page: 3971 issue: 10 year: 1974 ident: 1129_CR8 publication-title: Proc Natl Acad Sci doi: 10.1073/pnas.71.10.3971 – volume: 49 start-page: 18 issue: 1 year: 2013 ident: 1129_CR13 publication-title: Mol Cell doi: 10.1016/j.molcel.2012.10.015 – volume: 25 start-page: 4248 issue: 9 year: 2021 ident: 1129_CR52 publication-title: J Cell Mol Med doi: 10.1111/jcmm.16478 – volume: 2020 start-page: 8849218 year: 2020 ident: 1129_CR77 publication-title: Stem Cells Int doi: 10.1155/2020/8849218 – volume: 415 start-page: 11 year: 2018 ident: 1129_CR138 publication-title: Cancer Lett doi: 10.1016/j.canlet.2017.11.018 – year: 2021 ident: 1129_CR127 publication-title: ChemMedChem doi: 10.1002/cmdc.202100291 – volume: 69 start-page: 1028 issue: 6 year: 2018 ident: 1129_CR24 publication-title: Mol Cell doi: 10.1016/j.molcel.2018.02.015 – volume: 16 start-page: 2595 issue: 14 year: 2020 ident: 1129_CR108 publication-title: Int J Biol Sci doi: 10.7150/ijbs.45886 – volume: 37 start-page: 522 issue: 4 year: 2018 ident: 1129_CR76 publication-title: Oncogene doi: 10.1038/onc.2017.351 – volume: 144 start-page: 646 issue: 5 year: 2011 ident: 1129_CR17 publication-title: Cell doi: 10.1016/j.cell.2011.02.013 – volume: 13 start-page: 165 issue: 1 year: 2020 ident: 1129_CR46 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00990-3 – volume: 11 start-page: 624395 year: 2021 ident: 1129_CR136 publication-title: Front Oncol doi: 10.3389/fonc.2021.624395 – volume: 74 start-page: 640 issue: 4 year: 2019 ident: 1129_CR157 publication-title: Mol Cell doi: 10.1016/j.molcel.2019.04.025 – volume: 561 start-page: 556 issue: 7724 year: 2018 ident: 1129_CR160 publication-title: Nature doi: 10.1038/s41586-018-0538-8 – volume: 169 start-page: 985 issue: 6 year: 2017 ident: 1129_CR39 publication-title: Cell doi: 10.1016/j.cell.2017.05.016 – volume: 53 start-page: 91 issue: 1 year: 2021 ident: 1129_CR100 publication-title: Exp Mol Med doi: 10.1038/s12276-020-00510-w – volume: 35 start-page: 677 issue: 4 year: 2019 ident: 1129_CR162 publication-title: Cancer Cell doi: 10.1016/j.ccell.2019.03.006 – volume: 13 start-page: 117 issue: 1 year: 2020 ident: 1129_CR19 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00951-w – volume: 20 start-page: 608 issue: 10 year: 2019 ident: 1129_CR1 publication-title: Nat Rev Mol Cell Biol doi: 10.1038/s41580-019-0168-5 – volume: 11 start-page: 3717 issue: 1 year: 2020 ident: 1129_CR124 publication-title: Nat Commun doi: 10.1038/s41467-020-17495-9 – volume: 7 start-page: 25 year: 2019 ident: 1129_CR107 publication-title: Biomark Res doi: 10.1186/s40364-019-0178-7 – volume: 22 start-page: 976 issue: 9 year: 2016 ident: 1129_CR155 publication-title: Nat Med doi: 10.1038/nm.4165 – volume: 524 start-page: 150 issue: 1 year: 2020 ident: 1129_CR159 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2020.01.042 – volume: 12 start-page: 76 issue: 1 year: 2019 ident: 1129_CR113 publication-title: J Hematol Oncol doi: 10.1186/s13045-019-0760-3 – volume: 13 start-page: 90 issue: 1 year: 2020 ident: 1129_CR165 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00927-w – volume: 2 start-page: 647 issue: 9 year: 2002 ident: 1129_CR72 publication-title: Nat Rev Cancer doi: 10.1038/nrc883 – volume: 39 start-page: e103181 issue: 12 year: 2020 ident: 1129_CR74 publication-title: EMBO J doi: 10.15252/embj.2019103181 – volume: 160 start-page: 134 year: 2019 ident: 1129_CR62 publication-title: Biochem Pharmacol doi: 10.1016/j.bcp.2018.12.014 – volume: 11 start-page: 3588 issue: 12 year: 2020 ident: 1129_CR36 publication-title: J Cancer doi: 10.7150/jca.42338 – volume: 20 start-page: e13298 issue: 2 year: 2021 ident: 1129_CR143 publication-title: Aging Cell doi: 10.1111/acel.13298 – volume: 11 start-page: 659 issue: 8 year: 2020 ident: 1129_CR50 publication-title: Cell Death Dis doi: 10.1038/s41419-020-02847-6 – volume: 53 start-page: e12768 issue: 3 year: 2020 ident: 1129_CR140 publication-title: Cell Prolif doi: 10.1111/cpr.12768 – volume: 13 start-page: 159 issue: 1 year: 2020 ident: 1129_CR47 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-01000-2 – volume: 346 start-page: 1258096 issue: 6213 year: 2014 ident: 1129_CR147 publication-title: Science doi: 10.1126/science.1258096 – volume: 26 start-page: 463 issue: 8 year: 1973 ident: 1129_CR123 publication-title: J Antibiot (Tokyo) doi: 10.7164/antibiotics.26.463 – volume: 519 start-page: 482 issue: 7544 year: 2015 ident: 1129_CR3 publication-title: Nature doi: 10.1038/nature14281 – volume: 517 start-page: 581 issue: 4 year: 2019 ident: 1129_CR139 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2019.07.058 – volume: 12 start-page: 134 issue: 1 year: 2019 ident: 1129_CR88 publication-title: J Hematol Oncol doi: 10.1186/s13045-019-0818-2 – volume: 201 start-page: 289 issue: 2 year: 1988 ident: 1129_CR7 publication-title: J Mol Biol doi: 10.1016/0022-2836(88)90139-8 – volume: 35 start-page: e23655 issue: 3 year: 2021 ident: 1129_CR48 publication-title: J Clin Lab Anal doi: 10.1002/jcla.23655 – volume: 358 start-page: 1051 issue: 6366 year: 2017 ident: 1129_CR80 publication-title: Science doi: 10.1126/science.aao0409 – volume: 37 start-page: 270 issue: 3 year: 2020 ident: 1129_CR82 publication-title: Cancer Cell doi: 10.1016/j.ccell.2020.02.004 – volume: 13 start-page: 103 issue: 1 year: 2020 ident: 1129_CR161 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00924-z – volume: 3 start-page: 1233 issue: 11 year: 1997 ident: 1129_CR20 publication-title: RNA – volume: 11 start-page: 836 issue: 10 year: 2020 ident: 1129_CR53 publication-title: Cell Death Dis doi: 10.1038/s41419-020-03049-w – volume: 29 start-page: 571 issue: 2 year: 2021 ident: 1129_CR151 publication-title: Mol Ther doi: 10.1016/j.ymthe.2020.09.028 – volume: 722 start-page: 144076 year: 2020 ident: 1129_CR70 publication-title: Gene doi: 10.1016/j.gene.2019.144076 – volume: 11 start-page: 617174 year: 2020 ident: 1129_CR153 publication-title: Front Genet doi: 10.3389/fgene.2020.617174 – volume: 20 start-page: 1074 issue: 9 year: 2018 ident: 1129_CR54 publication-title: Nat Cell Biol doi: 10.1038/s41556-018-0174-4 – volume: 24 start-page: 12368 issue: 21 year: 2020 ident: 1129_CR58 publication-title: J Cell Mol Med doi: 10.1111/jcmm.15736 – volume: 79 start-page: 5785 issue: 22 year: 2019 ident: 1129_CR71 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-18-2868 – volume: 24 start-page: 499 issue: 4 year: 2018 ident: 1129_CR25 publication-title: RNA doi: 10.1261/rna.064063.117 – volume: 10 start-page: 115 year: 2020 ident: 1129_CR38 publication-title: Front Oncol doi: 10.3389/fonc.2020.00115 – volume: 10 start-page: 39 issue: 1 year: 2017 ident: 1129_CR61 publication-title: J Hematol Oncol doi: 10.1186/s13045-017-0410-6 – volume: 73 start-page: 108 issue: 1 year: 2021 ident: 1129_CR95 publication-title: IUBMB Life doi: 10.1002/iub.2410 – volume: 15 start-page: 88 issue: 1 year: 2019 ident: 1129_CR30 publication-title: Nat Chem Biol doi: 10.1038/s41589-018-0184-3 – volume: 12 start-page: 2159 issue: 1 year: 2021 ident: 1129_CR27 publication-title: Nat Commun doi: 10.1038/s41467-021-22424-5 – volume: 149 start-page: 22 issue: 1 year: 2012 ident: 1129_CR32 publication-title: Cell doi: 10.1016/j.cell.2012.03.003 – volume: 26 start-page: 3762 issue: 13 year: 2019 ident: 1129_CR121 publication-title: Cell Rep doi: 10.1016/j.celrep.2019.02.100 – volume: 19 start-page: 163 issue: 1 year: 2020 ident: 1129_CR42 publication-title: Mol Cancer doi: 10.1186/s12943-020-01281-8 – volume: 10 start-page: 58 issue: 1 year: 2017 ident: 1129_CR116 publication-title: J Hematol Oncol doi: 10.1186/s13045-017-0430-2 – volume: 13 start-page: 57 issue: 1 year: 2020 ident: 1129_CR158 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00895-1 – volume: 259 start-page: 113908 year: 2020 ident: 1129_CR63 publication-title: Environ Pollut doi: 10.1016/j.envpol.2019.113908 – volume: 33 start-page: 1234 issue: 6 year: 2021 ident: 1129_CR132 publication-title: Cell Metab doi: 10.1016/j.cmet.2021.03.024 – volume: 13 start-page: 109 issue: 1 year: 2020 ident: 1129_CR137 publication-title: J Hematol Oncol doi: 10.1186/s13045-020-00945-8 – volume: 8 start-page: 43 year: 2020 ident: 1129_CR166 publication-title: Biomark Res doi: 10.1186/s40364-020-00225-0 – volume: 12 start-page: 1394 issue: 1 year: 2021 ident: 1129_CR57 publication-title: Nat Commun doi: 10.1038/s41467-021-21514-8 – volume: 20 start-page: 1 year: 2020 ident: 1129_CR37 publication-title: Mol Ther Nucleic Acids doi: 10.1016/j.omtn.2020.01.033 – volume: 10 start-page: 383 issue: 6 year: 2019 ident: 1129_CR93 publication-title: Cell Death Dis doi: 10.1038/s41419-019-1585-2 – volume: 31 start-page: 345 issue: 3 year: 2021 ident: 1129_CR44 publication-title: Cell Res doi: 10.1038/s41422-020-00397-2 – volume: 169 start-page: 824 issue: 5 year: 2017 ident: 1129_CR4 publication-title: Cell doi: 10.1016/j.cell.2017.05.003 – volume: 7 start-page: 885 issue: 12 year: 2011 ident: 1129_CR12 publication-title: Nat Chem Biol doi: 10.1038/nchembio.687 – volume: 11 start-page: 797 issue: 9 year: 2020 ident: 1129_CR59 publication-title: Cell Death Dis doi: 10.1038/s41419-020-02998-6 – volume: 62 start-page: 335 issue: 3 year: 2016 ident: 1129_CR83 publication-title: Mol Cell doi: 10.1016/j.molcel.2016.03.021 – volume: 235 start-page: 7420 issue: 10 year: 2020 ident: 1129_CR87 publication-title: J Cell Physiol doi: 10.1002/jcp.29645 – volume: 39 start-page: e104514 issue: 20 year: 2020 ident: 1129_CR117 publication-title: EMBO J doi: 10.15252/embj.2020104514 – volume: 40 start-page: 132 issue: 1 year: 2021 ident: 1129_CR96 publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-021-01934-6 – volume: 485 start-page: 201 issue: 7397 year: 2012 ident: 1129_CR10 publication-title: Nature doi: 10.1038/nature11112 – volume: 12 start-page: 767 issue: 8 year: 2015 ident: 1129_CR5 publication-title: Nat Methods doi: 10.1038/nmeth.3453 – volume: 12 start-page: 15 issue: 1 year: 2013 ident: 1129_CR75 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2012.12.007 – volume: 56 start-page: 702 issue: 5 year: 2021 ident: 1129_CR145 publication-title: Dev Cell doi: 10.1016/j.devcel.2021.01.015 – volume: 47 start-page: 1025 issue: 12 year: 2008 ident: 1129_CR109 publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.20604 – volume: 12 start-page: 104 issue: 2 year: 2012 ident: 1129_CR101 publication-title: Nat Rev Cancer doi: 10.1038/nrc3185 |
| SSID | ssj0061920 |
| Score | 2.6306975 |
| SecondaryResourceType | review_article |
| Snippet | N6-methyladenosine (m6A) has emerged as an abundant modification throughout the transcriptome with widespread functions in protein-coding and noncoding RNAs.... Abstract N6-methyladenosine (m6A) has emerged as an abundant modification throughout the transcriptome with widespread functions in protein-coding and... |
| SourceID | doaj pubmedcentral proquest gale crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 1 |
| SubjectTerms | Biology Cancer Cancer Research Chemotherapy Drug discovery Epigenetics Gene expression Genes Genetic aspects Genomes Hematology Immunotherapy m6A m6A methyltransferase Medicine Medicine & Public Health Methyltransferase Methyltransferases MicroRNAs N6-methyladenosine Oncology Post-transcription Proteins Radiation therapy Review RNA polymerase Roles Therapy resistance Transcriptomes Tumorigenesis |
| SummonAdditionalLinks | – databaseName: Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB5BChUXHqWohgJGQuJAVvFzH1xQQVQg0SiHgspptV6vS6XKCUmK1H_PzHqdylT0xDHesezxzjM78w3A6wpdRl2agimTVqxoZMOkE4JVxjVKmdIpD7v4_auYTuXJiZqF9uhVKKvsbaI31B3aM9VtoxGe1HNL_5hP0FFnBfqmPH-_-MVohhSdtYaBGrdhi4C3khFszb4czX70lplyhaRvnJF8skrpmJBRkUJCYQeTA-fkMfyvW-rr1ZN_HaF6z3T44P_y9BDuhwg1PuhE6hHccu0O3O1mVl7uwPZROI1_DMdTzmgC9eW5qQlzHC_G3e-1D4fdEl3k6l1MvtOL9zheutMwL2wcm7aO-8bMeDGnt0Rl2IVvh5-OP35mYUoDsxgNrVlpcpfaHAMbtJRp0eSYxBlua2OaOlOlSJqmcim3svLDsJzLrFE1ZsMcF9JK5U9g1M5btwexKFRWZamVmK8XTSFMVTS8ShyGiUaYtIwg7bdH2wBhTpM0zrVPZSTX3ZZqfJL2W6plBG839yw6AI8bqT_Qrm8oCXzbX5gvT3XQZV1kprRZnSfWYIBjkYcSg16TS9RKW3AVwUuSGd11sm5MiD7gXNFAVJFE8MZTkBFBBqwJvRD4GQiOa0C5P6BE5bfD5V6ydDA-K30lSBG82izTnVRQ17r5BdFgKknAS8iyGMjzgPfhSnv20wOQyzzNpeQRjHvJv3r4v7_t05vf9Rncy7wqCpaJfRitlxfuOdyxv9dnq-WLoMp_AL4lWGg priority: 102 providerName: ProQuest – databaseName: Springer LINK dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEF-0ivSlfmNq1QiCD97SbHazH761YvFBD8Fa-rZsNhstHLmSpAX_e2c2yUlaFfQx2VlyOzef7MxvCHlVgsuoCieocaykotY11UEpWrpQG-OKYCLs4slHtVzq01PzeWwK66Zq9-lKMlrqqNZa7ncML_UolhRkGCRQfZPcKhBtBnP0LyeT_cWMIJvaY367b-aCIlL_dXt8vUbyykVp9D9Hd__vl98jO2O8mR4MAnKf3AjNA3Ln03ij_pAcLyXFKdI_Vq5C3HB4mQ7PfQxpQwturnubov-LIrpI22F8PTwsUtdU6dRcmZ6ve6w9cqtH5OvR--N3H-g4aYF6iGh6WjgemOcQnIC1Y6LmkIg56Svn6io3hcrqugxMel3GgVYh5N6ZCjJaCQusNPwx2WrWTXhCUiVMXubMa8i5RS2UK0UtyyxAqOeUY0VC2MR860cYcpyGsbIxHdHSDuyy8CUb2WV1Qt5s9pwPIBx_pT7E_3RDiQDa8cW6_WZHfbQid4XPK555B0GKhzMUELg6rkGzvJAmIS9QIuzQjboxA_ZASoNDTVWWkNeRAg0BHMC7sZ8B2ICQWjPKvRklKLCfL09SZ0cD0lmIRHMBwRfnCXm5WcadWBTXhPUF0kA6iOBJcGQ1k9bZ2ecrzdn3CCKuOeNay4QsJpn99fE_83b338ifku08ir2iudojW317EZ6R2_6yP-va51FtfwIgeT6f priority: 102 providerName: Springer Nature |
| Title | N6-methyladenosine methyltransferases: functions, regulation, and clinical potential |
| URI | https://link.springer.com/article/10.1186/s13045-021-01129-8 https://www.proquest.com/docview/2562481233 https://www.proquest.com/docview/2555965608 https://pubmed.ncbi.nlm.nih.gov/PMC8313886 https://doaj.org/article/42a5c2d30ca242c1b95575a38eadc469 |
| Volume | 14 |
| WOSCitedRecordID | wos000678066100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central Open Access Free customDbUrl: eissn: 1756-8722 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061920 issn: 1756-8722 databaseCode: RBZ dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: Directory of Open Access Journals (DOAJ) customDbUrl: eissn: 1756-8722 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061920 issn: 1756-8722 databaseCode: DOA dateStart: 20080101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1756-8722 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061920 issn: 1756-8722 databaseCode: M~E dateStart: 20080101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1756-8722 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061920 issn: 1756-8722 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1756-8722 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061920 issn: 1756-8722 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1756-8722 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061920 issn: 1756-8722 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: Springer LINK customDbUrl: eissn: 1756-8722 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0061920 issn: 1756-8722 databaseCode: RSV dateStart: 20081201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9RAEB-0ivgiftJoPSMIPnhLs_nYD99aaVGwx1FrOZ-WzWaDhSNX7lLB_96ZTXIai_riS2CzE5L9ZT7Z2RmAVyWajKqwOdOWlyyvVc2Ul5KV1tda28LrUHbx_KOczdRioee_tPqinLCuPHAH3H6e2sKlVZY4i9bE8VIX6GHYTCEEDmM70r6J1EMw1elgigqS4YiMEvsbThuCjNIREnIwmBqZoVCt_7pOvp4n-dtmabBBx_fhXu88xgfdRz-AG755CHdO-u3xR3A2E4xaQn9f2oqKgOPNuBu3wT_1a7RZm7cxGbPAb9N43fWix8E0tk0VDycl48tVS4lEdvkYPh8fnb17z_q2Ccyhe9IyBMdzl6GngaqL53WGUZUVrrK2rlJdyKSuS8-FU2XoTuV96qyuMDwVOIH4Zk9gp1k1fhdimeu0TLlTGEDndS5tmdeiTDz6bVZaXkTABxSN62uKU2uLpQmxhRKmQ97gm0xA3qgI3myfuewqavyV-pB-zpaSqmGHG8gjpucR8y8eieAF_VrTHS3dyrQ5EEJTh1KZRPA6UJBU4wKc7Q8nIAxUH2tEuTeiRGl04-mBfUyvDTYG3co0R08qyyJ4uZ2mJynDrfGrK6LB2I4qIeGS5YjtRmsfzzQXX0NFcJXxTCkRwXRg0J8v_zO2T_8Hts_gbhrkSrJU7sFOu77yz-G2-9ZebNYTuCkXMlzVBG4dHs3mp5MgqTiafziZf8HR6afzH2vZQMQ |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELemDhgvfAwQgcGCBOKBWkscJ3aQEBof06q1VR8KGk_GcZxtUpWWtgP1n-Jv5M5JOoWJve2Bx8QXJefe_e6uvg9CXmZgMvJYc5rqMKO8kAWVVgiaaVukqY5t6toufu2L4VAeH6ejDfK7qYXBtMoGEx1Q51OD_5HvgWlmHKxRFL2f_aA4NQpPV5sRGpVYHNnVLwjZFu96n-D3fcXYwefxx0NaTxWgBqz3ksY6sqGJwBCDZoe8iCDo0InJtS5ylsYiKIrMhomRmRveZC0zOs0hektgIcyw-RJA_iYHYQ86ZHPUG4y-NdiP0UjQlObIZG8R4kEkxTSIAB0bKlvmz00JuGwLLudn_nVI62zfwd3_bdfukTu1l-3vV2pxn2zYcpvcrOZurrbJrUGdUfCAjIcJxSnaq4nOsW863PSr66Vz6e0czPzirY_236lo15_bk3rmWdfXZe43xaX-bLrE3Cs9eUi-XAt3j0innJb2MfEFT1nGQiMFZ7zgQme8SLLAgqurhQ5jj4SNAChTt2HHaSAT5cIxmahKaBS8STmhUdIjb9bPzKomJFdSf0C5WlNiA3F3Yzo_UTUeKc50bFgeBUaDk2aAhxgcdx1JQBbDk9QjuyiVqqrGXcOg2k-SFIe6isAjrx0FAiEwYHRdzwHbgC3FWpQ7LUoAMNNebmRX1QC6UBeC65EX62V8EpMCSzs9RxoIh7F5FLAsWhrT4r29Up6duibqMgojKROPdBvdunj5v_f2ydXfuku2DseDvur3hkdPyW3mFF9QJnZIZzk_t8_IDfNzebaYP6-Bwyffr1vr_gBsJqw2 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagoKoX3lUDhQYJiQNrNU4cP7iVxwpEWVVQqt4sx7GhUpVd7aZI_HtmnGQhFJAQx8RjJWPPjL-R50HIkwqOjLq0nGrLKsqDClR5KWllfdDall7Hsosnh3I2U6en-uinLP4Y7T5cSXY5DVilqWn3F3XoVFyJ_RXDCz6K4QUZAgaqrpJrHDwZDOr68PFksMXoHWRDqsxv542Oo1i1_7Jtvhwv-culaTyLpjf_n4tb5EaPQ9ODTnBukyu-uUM23_c37XfJ8UxQ7C797dzWWE8cXqbdcxuhrl_C8bd6nuK5GEV3ki67tvbwMEltU6dD0mW6mONPgaDfI5-mr49fvqF9BwbqAOm0tLSFZ64A0AJWkPFQgINmhautDXWuS5mFUHkmnKpioyvvc2d1DZ6ugAFW6WKbbDTzxu-QVHKdVzlzCnxxHri0FQ-iyjxAQCstKxPCho0wri9Pjl0yzk10U5Qw3XIZ-JKJy2VUQp6t5yy64hx_pX6B-7umxMLa8cV8-dn0emp4bkuX10XmLIAXBzyUAGhtoUDjHBc6IXsoHabLUl2bB3MghMZmpzJLyNNIgQYCGHC2z3OAZcBSWyPK3RElKLYbDw8SaHrDsjKAUHMOoKwoEvJ4PYwzMViu8fMLpAE3EYsqActyJLkj3scjzdmXWFxcFaxQSiRkMsjvj4__eW3v_xv5Htk8ejU1h29n7x6QrTxqgKS53CUb7fLCPyTX3df2bLV8FLX5O2lRSmc |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=N6-methyladenosine+methyltransferases%3A+functions%2C+regulation%2C+and+clinical+potential&rft.jtitle=Journal+of+hematology+and+oncology&rft.au=Wei+Huang&rft.au=Tian-Qi+Chen&rft.au=Ke+Fang&rft.au=Zhan-Cheng+Zeng&rft.date=2021-07-27&rft.pub=BMC&rft.eissn=1756-8722&rft.volume=14&rft.issue=1&rft.spage=1&rft.epage=19&rft_id=info:doi/10.1186%2Fs13045-021-01129-8&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_42a5c2d30ca242c1b95575a38eadc469 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-8722&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-8722&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-8722&client=summon |